BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/08/2017

FDA Clears CENESTIN Tablets for Approval

The FDA has determined that CENESTIN Tablets in various doses were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →